Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Learn which credit cards come with no fees. Find your ideal match and save money on annual costs!
26,626 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
SpaceX stock surged after its open, then cooled as investors digest fundamentals and macro conditions. This article e...
Comcast announced a UK broadcaster acquisition just days after revealing NBCUniversal’s spin-off plan, signaling a bo...
Ford and Tesla report contrasting Q1 2026 results, underscoring two paths for American manufacturing. Investors weigh...
Solana (sol) hits 2026 high in headlines as sentiment worsens, yet new on-chain activity and a fresh technical setup ...
Is a $5 trillion Apple valuation possible by the end of 2026? This guide weighs the growth engines, risks, and action...
Apple pushes to a fresh all-time high as AI-enabled products and a robust services ecosystem drive growth. The move w...
Palo Alto Networks stock surged as traders rotated into cybersecurity in a market shifting away from legacy software....
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
A new wave of pre-IPO trading is reshaping access to private company bets. This guide breaks down why traders are flo...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...